
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+1
Zelluna Immunotherapy is a company pioneering the development of allogeneic T cell receptor (TCR) guided natural killer (NK) cell immunotherapies for the treatment of solid cancers. The company is developing a portfolio of tumor specific TCRs to guide NK cells with the aim to induce cancer responses that are safe, efficient and durable. For more info please visit www.zelluna.com
Cancer treatment,immunotherapy,adoptive cell therapy,t cell receptor technologies,immunooncology,and solid tumors
Zelluna immunotherapy operates in the Biotechnology research industry.
Zelluna immunotherapy's revenue is 11m - 100m
Zelluna immunotherapy has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.